Archives

  • 2018-07
  • 2018-10
  • 2018-11
  • 2019-04
  • 2019-05
  • 2019-06
  • 2019-07
  • 2019-08
  • 2019-09
  • 2019-10
  • 2019-11
  • 2019-12
  • 2020-01
  • 2020-02
  • 2020-03
  • 2020-04
  • 2020-05
  • 2020-06
  • 2020-07
  • 2020-08
  • 2020-09
  • 2020-10
  • 2020-11
  • 2020-12
  • 2021-01
  • 2021-02
  • 2021-03
  • 2021-04
  • 2021-05
  • 2021-06
  • 2021-07
  • 2021-08
  • 2021-09
  • 2021-10
  • 2021-11
  • 2021-12
  • 2022-01
  • 2022-02
  • 2022-03
  • 2022-04
  • 2022-05
  • 2022-06
  • 2022-07
  • 2022-08
  • 2022-09
  • 2022-10
  • 2022-11
  • 2022-12
  • 2023-01
  • 2023-02
  • 2023-03
  • 2023-04
  • 2023-05
  • 2023-06
  • 2023-07
  • 2023-08
  • 2023-09
  • 2023-10
  • 2023-11
  • 2023-12
  • 2024-01
  • 2024-02
  • 2024-03
  • 2024-04
  • In high income settings the prevalence of

    2019-07-01

    In high-income settings, the prevalence of tobacco use has been shown to be significantly higher in people living with HIV than among HIV-negative individuals of the same age and sex distribution. This at-risk pattern is one of the biggest threats to the number of years of life saved with antiretroviral therapy (ART). Extrapolation of these findings to low-income and middle-income countries (LMICs) is risky because social, cultural, and behavioural factors influencing tobacco use differ widely across different regions. The epidemiology of tobacco use in HIV-positive individuals in LMICs has been sparsely reported, with limited representativeness and no or biased control populations. In , Noreen Mdege and colleagues report an unprecedented estimation of tobacco use in people living with HIV, using nationally representative samples extracted from the Demographic and Health Surveys (DHS) from 28 countries on three continents. In addition to depicting the burden and diversity of tobacco use, the authors show significantly higher figures of tobacco use in people living with HIV compared with their HIV-negative counterparts, regardless of gender. These results confirm what has already been reported in high-income settings, and emphasise the need for adapted preventive measures and tobacco cessation programmes in LMICs.
    The world now faces the next step in HIV management. We are in an era beyond treatment and viral suppression. The widespread roll out of antiretroviral treatment and good HIV testing programmes within pregnancy might substantially change vertical transmission rates globally. Lifelong treatment and innovations, such as those financed by the Global Fund, provide a pathway— indeed a lifeline—for survival. Yet, the scars of an epidemic are deep. Exposure to trauma and loss can affect children and youth for many years. Interventions for such trauma are improving, but recent reviews suggest a need for more solid evidence. In , Tonya Thurman and colleagues\' study provides a randomised controlled evaluation of an intervention for bereaved adolescent girls in South Africa. As such, it marks an important shift in the evidence vegf inhibitor and contributes to the growing provision in this area as well as providing usable tools. Mental health effects of the HIV epidemic are not only a key consideration, but might have been neglected especially in contexts of greatest resource constraints. The infrastructure and provision of mental health services in low-income and middle-income settings needs urgent attention. This study—despite specific limitations—is a clear example of potential provision and a way forward. The study showed effective impacts of a brief therapeutic intervention, including significantly lower intrusive grief, depression, and behaviour problems, and higher support. The intervention was confined to those who were willing to be included. However, it is well established in the psychological therapies that motivation and willingness for support is a pre-requisite for successful intervention. The study was confined to adolescent girls—again clearly noting a gap for adolescent boys who might have equal need, but could require adjusted interventions and different strategies to both reach them and to do so effectively. There is a growing body of evidence showing the efficacy of complex interventions for improving wellbeing and reducing adolescent risk behaviour. A recent Cochrane review identified only 16 quality trials of psychological interventions for adults affected by HIV. The evidence base for adolescents is even less robust. Emerging reports show the nature of mental health burden experienced by adolescents and forms of effective provision, such as client centred approaches in Ethiopia. This study adds to the evidence base—especially for adolescents where the data are much more limited. It marks the importance of the mental health burden of bereavement on adolescents—especially heightened by the many parental deaths within high endemic HIV settings. The study also explored the links between mental health and behaviour and showed how a brief intervention could reduce intrusive grief as well as reduce adult reported behavioural problems. As such, this small study is an example of the next generation of vital interventions. Acknowledgement of mental health issues is needed—especially in children and youth, and an active attempt needs to be made to measure this and to provide responsive pathways for redress.